Abbott Laboratories Raises Full-Year Profit Forecast After Strong Q2 Results
Shares of Abbott Laboratories (NYSE: ABT) rose after the company reported strong second-quarter results and raised its full-year profit forecast. The acquisition of Exact Sciences contributed to a 13% sales increase, with diagnostics revenue surging by over 40%. Management now expects adjusted earnings per share between $5.45 and $5.60 for 2026.